Currently, there are 472.50M common shares owned by the public and among those 378.19M shares have been available to trade.
The company’s stock has a 5-day price change of -6.22% and -11.34% over the past three months. BITF shares are trading -27.49% year to date (YTD), with the 12-month market performance up to 81.90% higher. It has a 12-month low price of $1.01 and touched a high of $3.91 over the same period. BITF has an average intraday trading volume of 25.71 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.20%, 2.53%, and -7.68% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Bitfarms Ltd (NASDAQ: BITF) shares accounts for 19.46% of the company’s 472.50M shares outstanding.
It has a market capitalization of $1.44B and a beta (3y monthly) value of 3.36. The earnings-per-share (ttm) stands at -$0.34. Price movements for the stock have been influenced by the stock’s volatility, which stands at 11.93% over the week and 9.95% over the month.
Earnings per share for the fiscal year are expected to increase by 52.92%, and 141.42% over the next financial year.
Looking at the support for the BITF, a number of firms have released research notes about the stock. Cantor Fitzgerald stated their Overweight rating for the stock in a research note on June 11, 2024, with the firm’s price target at $4-$5. H.C. Wainwright coverage for the Bitfarms Ltd (BITF) stock in a research note released on June 04, 2024 offered a Buy rating with a price target of $4. B. Riley Securities was of a view on December 14, 2023 that the stock is Buy, while Cantor Fitzgerald gave the stock Overweight rating on May 19, 2023, issuing a price target of $2.
